Unknown

Dataset Information

0

SPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage.

ABSTRACT: Fibrosis results from inflammatory tissue damage and impaired regeneration. In the context of bleomycin-induced pulmonary fibrosis, we demonstrated that the matricellular protein termed secreted protein acidic and rich in cysteine (SPARC) distinctly regulates inflammation and collagen deposition, depending on its cellular origin. Reciprocal Sparc(-/-) and wild-type (WT) bone marrow chimeras revealed that SPARC expression in host fibroblasts is required and sufficient to induce collagen fibrosis in a proper inflammatory environment. Accordingly, Sparc(-/-) >WT chimeras showed exacerbated inflammation and fibrosis due to the inability of Sparc(-/-) macrophages to down-regulate tumor necrosis factor production because of impaired responses to tumor growth factor-?. Hence, the use of bone marrow cells expressing a dominant-negative form of tumor growth factor-? receptor type II under the monocyte-specific CD68 promoter, as a decoy, phenocopied Sparc(-/-) donor chimeras. Our results point to an unexpected dual role of SPARC in oppositely influencing the outcome of fibrosis.

SUBMITTER: Sangaletti S 

PROVIDER: S-EPMC3260886 | biostudies-other | 2011 Dec

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

SPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage.

Sangaletti Sabina S   Tripodo Claudio C   Cappetti Barbara B   Casalini Patrizia P   Chiodoni Claudia C   Piconese Silvia S   Santangelo Alessandra A   Parenza Mariella M   Arioli Ivano I   Miotti Silvia S   Colombo Mario P MP  

The American journal of pathology 20111011 6

Fibrosis results from inflammatory tissue damage and impaired regeneration. In the context of bleomycin-induced pulmonary fibrosis, we demonstrated that the matricellular protein termed secreted protein acidic and rich in cysteine (SPARC) distinctly regulates inflammation and collagen deposition, depending on its cellular origin. Reciprocal Sparc(-/-) and wild-type (WT) bone marrow chimeras revealed that SPARC expression in host fibroblasts is required and sufficient to induce collagen fibrosis  ...[more]

Similar Datasets

Unknown Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis.
| S-EPMC3212807 | biostudies-other
Unknown Prostaglandin D2 Attenuates Bleomycin-Induced Lung Inflammation and Pulmonary Fibrosis.
| S-EPMC5167321 | biostudies-literature
Unknown The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis.
| S-EPMC3669327 | biostudies-literature
Unknown Salt-inducible kinase 2 regulates fibrosis during bleomycin-induced lung injury.
| S-EPMC9706632 | biostudies-literature
Unknown The LIM-only protein FHL2 attenuates lung inflammation during bleomycin-induced fibrosis.
| S-EPMC3832604 | biostudies-literature
Unknown Acid sphingomyelinase deficiency attenuates bleomycin-induced lung inflammation and fibrosis in mice.
| S-EPMC3048941 | biostudies-literature
Unknown CD36, but not G2A, modulates efferocytosis, inflammation, and fibrosis following bleomycin-induced lung injury.
| S-EPMC3605987 | biostudies-literature
Unknown Engineered Fibroblast Extracellular Vesicles Attenuate Pulmonary Inflammation and Fibrosis in Bleomycin-Induced Lung Injury.
| S-EPMC8512699 | biostudies-literature
Unknown The effect of class II transactivator mutations on bleomycin-induced lung inflammation and fibrosis.
| S-EPMC3135849 | biostudies-other
Unknown A novel multikinase inhibitor SKLB-YTH-60 ameliorates inflammation and fibrosis in bleomycin-induced lung fibrosis mouse models.
| S-EPMC8249783 | biostudies-literature